November 4, 2022
Life Sciences
  • Pfizer Inc. said that a new study shows its updated COVID-19 booster, developed with BioNTech SE, increased antibodies for adults 55 and over compared with an extra dose of the original vaccine. The Food and Drug Administration (FDA) said that the new data should help motivate Americans to get the omicron-targeting updated shots. (Article here)